{
  "nctId": "NCT02238639",
  "briefTitle": "Pulmonary Embolism as a Cause of COPD Exacerbations",
  "officialTitle": "Efficacy and Safety of an Active Strategy for the Diagnosis and Treatment of Acute Pulmonary Embolism (PE) in Patients With Unexplained Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): a Randomized Clinical Trial",
  "protocolDocument": {
    "nctId": "NCT02238639",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2018-09-03",
    "uploadDate": "2021-12-09T02:48",
    "size": 482222,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02238639/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 746,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2014-10",
    "completionDate": "2020-12",
    "primaryCompletionDate": "2020-10",
    "firstSubmitDate": "2014-09-09",
    "firstPostDate": "2014-09-12"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Confirmation of COPD according to SEPAR-ALT criteria: post-bronchodilator forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) \\< 0.7;\n* Hospital admission because COPD exacerbation without initial clinical suspicion of PE in the Emergency Department (according by the Emergency Department physician evaluation).\n\nExclusion Criteria:\n\n* Contraindication to multidetector computed tomographic angiography (allergy to intravenous contrast medium, or renal failure defined as a creatinine clearance less than 30 mL/min, according to the Cockcroft-Gault formula)\n* Informed consent denied\n* Pregnancy\n* Life expectancy less than 3 months\n* Anticoagulant therapy at the time of hospital admission\n* Diagnosis of pneumothorax, or pneumonia (fever, and purulent sputum, and new infiltrate in chest X-ray)\n* Diagnosis of lower respiratory tract infection (fever \\[\\>37.8ÂºC\\], increased sputum volume and/or increased sputum purulence).\n* Indication of invasive mechanical ventilation at the time of hospital admission;\n* Impossibility for follow-up.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "All-cause Mortality, Symptomatic Venous Thromboembolism Recurrence, or Need for Readmission.",
        "description": "Clinical composite endpoint of all-cause mortality, or symptomatic venous thromboembolism recurrence, or need for readmission.",
        "timeFrame": "90-day follow-up"
      }
    ],
    "secondary": [
      {
        "measure": "All-cause Mortality",
        "description": "All-cause mortality.",
        "timeFrame": "90-day follow-up"
      },
      {
        "measure": "Symptomatic Recurrent Venous Thromboembolism",
        "description": "Symptomatic venous thromboembolic recurrence confirmed by objective testing.",
        "timeFrame": "90-day follow-up"
      },
      {
        "measure": "Hospitalization",
        "description": "Need for readmission.",
        "timeFrame": "90-day follow-up"
      },
      {
        "measure": "Major Bleeding",
        "description": "Major bleeding (defined according to previously published criteria)",
        "timeFrame": "90-day follow-up"
      },
      {
        "measure": "Clinically Relevant Non Major Bleeding",
        "description": "Clinically relevant non major bleeding (defined according to previously published criteria)",
        "timeFrame": "90-day follow-up"
      },
      {
        "measure": "Serious Adverse Events",
        "description": "Serious adverse events.",
        "timeFrame": "90-day follow-up"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 6,
      "otherCount": 0,
      "totalCount": 7
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 54,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:29:26.296Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}